Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
Esser AK, Ross MH, Fontana F, Su X, Gabay A, Fox GC, Xu Y, Xiang J, Schmieder AH, Yang X, Cui G, Scott M, Achilefu S, Chauhan J, Fletcher S, Lanza GM, Weilbaecher KN. Esser AK, et al. Among authors: fletcher s. Theranostics. 2020 Jun 12;10(17):7510-7526. doi: 10.7150/thno.44523. eCollection 2020. Theranostics. 2020. PMID: 32685002 Free PMC article.
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival.
Fontana F, Scott MJ, Allen JS, Yang X, Cui G, Pan D, Yanaba N, Fiala MA, O'Neal J, Schmieder-Atteberry AH, Ritchey J, Rettig M, Simons K, Fletcher S, Vij R, DiPersio JF, Lanza GM. Fontana F, et al. Among authors: fletcher s. Clin Cancer Res. 2021 Apr 1;27(7):1974-1986. doi: 10.1158/1078-0432.CCR-20-2839. Epub 2020 Dec 22. Clin Cancer Res. 2021. PMID: 33355244 Free PMC article.
Mcl-1 inhibitors: a patent review.
Chen L, Fletcher S. Chen L, et al. Among authors: fletcher s. Expert Opin Ther Pat. 2017 Feb;27(2):163-178. doi: 10.1080/13543776.2017.1249848. Epub 2016 Nov 17. Expert Opin Ther Pat. 2017. PMID: 27744724 Review.
MCL-1 inhibitors - where are we now (2019)?
Fletcher S. Fletcher S. Expert Opin Ther Pat. 2019 Nov;29(11):909-919. doi: 10.1080/13543776.2019.1672661. Epub 2019 Oct 14. Expert Opin Ther Pat. 2019. PMID: 31566022 Review.
Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone - A novel class of compounds with potent activity against acute myeloid leukemia cells.
Carter-Cooper BA, Fletcher S, Ferraris D, Choi EY, Kronfli D, Dash S, Truong P, Sausville EA, Lapidus RG, Emadi A. Carter-Cooper BA, et al. Among authors: fletcher s. Bioorg Med Chem Lett. 2017 Jan 1;27(1):6-10. doi: 10.1016/j.bmcl.2016.11.045. Epub 2016 Nov 17. Bioorg Med Chem Lett. 2017. PMID: 27890379 Free PMC article.
1,485 results